Dr. Brian O’Rourke, president and CEO of CADTH, presents the organization’s main programs and the strategies it has put in place in order to ensure excellence in the future as they face reforms in the country’s healthcare system. Adaptation to stakeholder needs, including those of the pharmaceutical industry, and to new drug forms will be required to maintain CADTH’s reputation and ensure successful outcomes.
Can you please introduce CADTH’s mandate to our international readers?
"Our engagement with industry is equally proactive, collaborative, and transparent."
